2m 2m 2m 2m 2m 2m 2m
Zoetis-A (ZTS)
NYSE
$75.10-$0.29 (-0.38%)
Price as of Jul 13, 2026 8:00 PM EDT- $31.5BMarket Cap
- -50.48%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zoetis-A (ZTS)
$75.10-$0.29 (-0.38%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.5B +2.28% | 9.3B +8.33% | 8.5B +5.74% | 8.1B +3.91% | |
Cost of Revenue | 2.7B -1.95% | 2.7B +6.17% | 2.6B +4.36% | 2.5B +6.56% | |
Gross Profit | 4.3B +2.83% | 4.1B +13.21% | 3.7B +4.13% | 3.5B +7.87% | |
Sales and Marketing Expense | 2.4B +2.59% | 2.3B +7.76% | 2.2B +7.07% | 2.0B +0.40% | |
Research and Development Expense | -698.0M +1.75% | -686.0M +11.73% | -614.0M +13.91% | -539.0M +6.10% | |
Depreciation and Amortization Expense | 487.0M -2.01% | 497.0M +1.22% | 491.0M +5.59% | 465.0M +3.79% | |
Total Operating Expenses | 2.7B -1.95% | 2.7B +6.17% | 2.6B +4.36% | 2.5B +6.56% | |
Operating Profit | 3.4B +7.25% | 3.1B +6.71% | 2.9B +10.54% | 2.7B +6.75% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -222.0M -1.33% | -225.0M -5.86% | -239.0M +8.14% | -221.0M -1.34% | |
Interest Income and Expense and Net | -222.0M -1.33% | -225.0M -5.86% | -239.0M +8.14% | -221.0M -1.34% | |
Total Nonoperating Income and Expense | 36.0M +89.47% | 19.0M -88.05% | 159.0M +497.50% | -40.0M -16.67% | |
Income before Taxes | 3.4B +7.25% | 3.1B +6.71% | 2.9B +10.54% | 2.7B +6.75% | |
Income Taxes | 687.0M +7.85% | 637.0M +6.88% | 596.0M +9.36% | 545.0M +20.04% | |
Extraordinary Items | 47.0M +51.61% | 31.0M -32.61% | 46.0M -13.21% | 53.0M +12.77% | |
Net Income | 2.7B +7.52% | 2.5B +6.06% | 2.3B +10.88% | 2.1B +3.78% | |
Net Income from Continuing Operations Applicable to Common | 3.4B +7.25% | 3.1B +6.71% | 2.9B +10.54% | 2.7B +6.75% | |
Basic EPS and Net Income | 6.03 +10.24% | 5.47 +7.68% | 5.08 +12.64% | 4.51 +5.13% | |
Diluted EPS and Net Income | 6.02 +10.05% | 5.47 +7.89% | 5.07 +12.92% | 4.49 +5.15% | |
Basic Weighted Average Shares | 443.4M -2.37% | 454.2M -1.51% | 461.2M -1.65% | 468.9M -1.15% | |
Diluted Weighted Average Shares | 443.8M -2.42% | 454.8M -1.61% | 462.3M -1.73% | 470.4M -1.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.3B +16.36% | 2.0B -2.65% | 2.0B -43.00% | 3.6B +2.75% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.3B +16.36% | 2.0B -2.65% | 2.0B -43.00% | 3.6B +2.75% | |
Total Current Assets | 6.8B +13.06% | 6.0B -5.63% | 6.3B -15.49% | 7.5B +8.31% | |
Accumulated Depreciation | 2.9B +11.01% | 2.6B +1.58% | 2.6B +12.93% | 2.3B +10.86% | |
Property and Plant and Equipment and Net | 3.7B +8.55% | 3.4B +5.84% | 3.2B +16.38% | 2.8B +13.67% | |
Total Long-Term Assets | 328.0M +31.20% | 250.0M +21.36% | 206.0M +40.14% | 147.0M +32.43% | |
Total Assets | 15.5B +8.64% | 14.2B -0.34% | 14.3B -4.28% | 14.9B +7.37% | |
Income Taxes Payable | 562.0M +5.64% | 532.0M +0.95% | 527.0M -5.39% | 557.0M -9.43% | |
Total Short-Term Debt | 0 -100.00% | 1.4B +44,900.00% | 3.0M -99.78% | 1.4B N/A | |
Total Current Liabilities | 2.2B -34.50% | 3.4B +80.62% | 1.9B -40.35% | 3.2B +76.24% | |
Total Long-Term Debt | 9.0B +73.22% | 5.2B -20.48% | 6.6B +0.18% | 6.6B -0.61% | |
Total Long-Term Liabilities | 248.0M +11.71% | 222.0M -6.33% | 237.0M +9.22% | 217.0M -9.21% | |
Total Liabilities | 12.1B +28.19% | 9.5B +1.85% | 9.3B -11.66% | 10.5B +12.46% | |
Retained Earnings | 13.7B +14.84% | 12.0B +16.25% | 10.3B +18.77% | 8.7B +20.62% | |
Total Stockholders Equity | 3.3B -30.17% | 4.8B -4.54% | 5.0B +13.44% | 4.4B -3.04% | |
Total Shares Outstanding | 424.9M -5.25% | 448.5M -2.16% | 458.4M -1.17% | 463.8M -1.85% | |
Cash Flow | |||||
Cash from Operating Activities | 2.9B -1.66% | 3.0B +25.50% | 2.4B +23.06% | 1.9B -13.60% | |
Capital Expenditures | 621.0M -5.19% | 655.0M -10.52% | 732.0M +24.91% | 586.0M +22.85% | |
Cash from Investing Activities | -748.0M +137.46% | -315.0M -59.46% | -777.0M -12.00% | -883.0M +92.79% | |
Dividends Paid | 889.0M +13.10% | 786.0M +13.58% | 692.0M +13.26% | 611.0M +28.90% | |
Cash from Financing Activities | -1.9B -29.70% | -2.7B -14.44% | -3.1B +243.92% | -904.0M -51.45% | |
Financials Ratio | |||||
Gross Margin | 71.84% +1.72% | 70.62% +0.86% | 70.03% +0.57% | 69.63% -1.07% | |
Operating Margin | 35.49% +4.86% | 33.85% -1.50% | 34.36% +4.54% | 32.87% +2.74% | |
Return on Assets | 18.00% +3.25% | 17.43% +8.62% | 16.05% +9.41% | 14.67% -0.96% | |
Return on Equity | 65.99% +29.63% | 50.91% +2.09% | 49.86% +5.53% | 47.25% -3.60% | |
Revenue Growth | 2.28% -72.64% | 8.33% +45.11% | 5.74% +46.89% | 3.91% -76.30% | |
Current Ratio | 3.03 +72.61% | 1.75 -47.75% | 3.36 +41.68% | 2.37 -38.54% | |
Cash Ratio | 1.03 +77.63% | 0.58 -46.10% | 1.08 -4.44% | 1.13 -41.70% | |
Debt-to-Equity Ratio | 2.71 +97.07% | 1.38 +4.81% | 1.31 -26.76% | 1.79 +23.66% | |
Debt-to-Assets Ratio | 0.58 +26.67% | 0.46 +0.39% | 0.46 -13.20% | 0.53 +11.68% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow